Coverage
-
January 22, 2019
A unit of Valeant Pharmaceuticals can keep its false drug marketing claims against a subsidiary of rival Virtus Pharmaceuticals in California federal court, a judge has ruled, finding the dispute didn't have to go through the U.S. Food and Drug Administration first.
1 other articles on this case.
View all »